Inventor
ZHONG WENGE
US37 patents
⚠️ This page may combine multiple inventors who share the name “ZHONG WENGE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
18 patentsUS6822097B1Nov 23, 2004
Compounds and methods of uses
AMGEN INC23 citations91
US9718803B2Aug 1, 2017
Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
AMGEN INC8 citations84
US9303028B2Apr 5, 2016
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC4 citations84
US7872009B2Jan 18, 2011
Beta-Secretase modulators and methods of use
AMGEN INC11 citations82
US7119111B2Oct 10, 2006
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
AMGEN INC11 citations82
US9556135B2Jan 31, 2017
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
AMGEN INC2 citations72
US9174992B2Nov 3, 2015
Heterobicyclic compounds
AMGEN INC4 citations72
US9096527B2Aug 4, 2015
TRPM8 antagonists and their use in treatments
AMGEN INC5 citations72
US9012446B2Apr 21, 2015
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
AMGEN INC4 citations72
US8691986B2Apr 8, 2014
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC3 citations63
US9296734B2Mar 29, 2016
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC2 citations62
US7973047B2Jul 5, 2011
Beta-Secretase modulators and methods of use
AMGEN INC2 citations61
US7745484B2Jun 29, 2010
Beta-secretase modulators and methods of use
AMGEN INC2 citations60
US9493459B2Nov 15, 2016
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC0 citations52
US7951838B2May 31, 2011
Substituted spirocyclic chromanamine compounds as Beta-Secretase modulators and methods of use
AMGEN INC0 citations52
US7803809B2Sep 28, 2010
Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
AMGEN INC0 citations51
US7838676B2Nov 23, 2010
Beta-secretase modulators and methods of use
AMGEN INC1 citations50
US8952009B2Feb 10, 2015
Chroman derivatives as TRPM8 inhibitors
AMGEN INC0 citations41
QILU REGOR THERAPEUTICS INC
5 patentsUS10954221B2Mar 23, 2021
GLP-1R agonists and uses thereof
QILU REGOR THERAPEUTICS INC14 citations93
US10844049B2Nov 24, 2020
GLP-1R agonists and uses thereof
QILU REGOR THERAPEUTICS INC15 citations93
US12365670B2Jul 22, 2025
GLP-IR agonists and uses thereof
QILU REGOR THERAPEUTICS INC2 citations74
US11591321B2Feb 28, 2023
GLP-1R agonists and uses thereof
QILU REGOR THERAPEUTICS INC3 citations72
US12516041B2Jan 6, 2026
Crystal forms of GLP-1R agonists and uses thereof
QILU REGOR THERAPEUTICS INC0 citations58
ZHONG WENGE
5 patentsUS8552181B2Oct 8, 2013
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
ZHONG WENGE0 citations49
US8173810B2May 8, 2012
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
ZHONG WENGE0 citations49
US8163909B2Apr 24, 2012
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
ZHONG WENGE0 citations49
US8163766B2Apr 24, 2012
Beta-secretase modulators and methods of use
ZHONG WENGE0 citations48
US8633315B2Jan 21, 2014
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
ZHONG WENGE0 citations46
MINATTI ANA ELENA
2 patentsUS8921363B2Dec 30, 2014
Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors
MINATTI ANA ELENA4 citations71
US8957083B2Feb 17, 2015
Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
MINATTI ANA ELENA4 citations70